THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION
Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general population [2] and about 40–47% of the population acc...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1764 |
| _version_ | 1797841458276859904 |
|---|---|
| author | S. A. Berns R. I. Stryuk |
| author_facet | S. A. Berns R. I. Stryuk |
| author_sort | S. A. Berns |
| collection | DOAJ |
| description | Cardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general population [2] and about 40–47% of the population according to Russian studies. [3] The experts forecast that by 2030 the prevalence of hypertension will increase by approximately 10%. [4] |
| first_indexed | 2024-04-09T16:31:15Z |
| format | Article |
| id | doaj.art-d65428bead434323ae8544e010500e90 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:31:15Z |
| publishDate | 2017-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-d65428bead434323ae8544e010500e902023-04-23T06:57:06ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902017-12-0107171910.21518/2079-701X-2017-7-17-191746THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSIONS. A. Berns0R. I. Stryuk1Moscow State University of Medicine and Dentistry named after Evdokimov, MoH RFMoscow State University of Medicine and Dentistry named after Evdokimov, MoH RFCardiovascular diseases (CVD) remain the main cause of mortality in the world. [1] At the same time, arterial hypertension (AH) is one of the most common CV pathologies, which, according to foreign researchers, affects about 30–45% of the general population [2] and about 40–47% of the population according to Russian studies. [3] The experts forecast that by 2030 the prevalence of hypertension will increase by approximately 10%. [4]https://www.med-sovet.pro/jour/article/view/1764hypertensionrenal protective effectace inhibitorsfosinopril |
| spellingShingle | S. A. Berns R. I. Stryuk THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION Медицинский совет hypertension renal protective effect ace inhibitors fosinopril |
| title | THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION |
| title_full | THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION |
| title_fullStr | THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION |
| title_full_unstemmed | THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION |
| title_short | THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION |
| title_sort | place of fosinopril in evidence based treatment of patients with arterial hypertension |
| topic | hypertension renal protective effect ace inhibitors fosinopril |
| url | https://www.med-sovet.pro/jour/article/view/1764 |
| work_keys_str_mv | AT saberns theplaceoffosinoprilinevidencebasedtreatmentofpatientswitharterialhypertension AT ristryuk theplaceoffosinoprilinevidencebasedtreatmentofpatientswitharterialhypertension AT saberns placeoffosinoprilinevidencebasedtreatmentofpatientswitharterialhypertension AT ristryuk placeoffosinoprilinevidencebasedtreatmentofpatientswitharterialhypertension |